(RNR) Renaissancere Holdings - Overview
Exchange: NYSE •
Country: Bermuda •
Currency: USD •
Type: Common Stock •
ISIN: BMG7496G1033
Stock: Reinsurance, Insurance, Property, Casualty, Specialty
Total Rating 64
Risk 73
Buy Signal 0.03
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.64% |
| Yield on Cost 5y | 1.03% |
| Yield CAGR 5y | 2.67% |
| Payout Consistency | 99.3% |
| Payout Ratio | 4.0% |
| Risk 5d forecast | |
|---|---|
| Volatility | 26.4% |
| Relative Tail Risk | 0.00% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.86 |
| Alpha | 21.32 |
| Character TTM | |
|---|---|
| Beta | 0.334 |
| Beta Downside | 0.401 |
| Drawdowns 3y | |
|---|---|
| Max DD | 23.10% |
| CAGR/Max DD | 0.54 |
Description: RNR Renaissancere Holdings January 04, 2026
RenaissanceRe Holdings Ltd. (NYSE:RNR) is a Bermuda-based reinsurance group that underwrites both property catastrophe excess-of-loss contracts and a broad suite of casualty-and-specialty products for insurers worldwide, distributing primarily through intermediaries.
Key operating metrics (as of FY 2023) include net written premiums of $13.2 billion, a combined ratio of 96.5 % in the Property segment, and a loss-adjusted capital ratio of 5.8 ×, reflecting strong underwriting discipline and capital strength.
Sector drivers that materially affect RNR’s outlook are: (1) the accelerating frequency and severity of climate-related catastrophes, which lift demand for excess-of-loss cover; (2) rising interest rates that enhance investment income but can pressure the pricing of long-dated liabilities; and (3) the cyclical nature of reinsurance pricing, where soft markets compress margins while hard markets expand them.
For a deeper quantitative view, you might explore ValueRay’s detailed risk-adjusted performance metrics for RNR.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 2.68b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 0.47 > 1.0 |
| NWC/Revenue: -55.37% < 20% (prev -159.3%; Δ 103.9% < -1%) |
| CFO/TA 0.08 > 3% & CFO 3.99b > Net Income 2.68b |
| Net Debt (598.0m) to EBITDA (3.63b): 0.16 < 3 |
| Current Ratio: 0.67 > 1.5 & < 3 |
| Outstanding Shares: last quarter (44.9m) vs 12m ago -11.02% < -2% |
| Gross Margin: 35.28% > 18% (prev 0.32%; Δ 3497 % > 0.5%) |
| Asset Turnover: 25.69% > 50% (prev 22.97%; Δ 2.72% > 0%) |
| Interest Coverage Ratio: 5.30 > 6 (EBITDA TTM 3.63b / Interest Expense TTM 536.2m) |
Altman Z'' 0.54
| A: -0.14 (Total Current Assets 14.39b - Total Current Liabilities 21.48b) / Total Assets 48.91b |
| B: 0.22 (Retained Earnings 10.83b / Total Assets 48.91b) |
| C: 0.06 (EBIT TTM 2.84b / Avg Total Assets 49.81b) |
| D: 0.37 (Book Value of Equity 10.86b / Total Liabilities 29.70b) |
| Altman-Z'' Score: 0.54 = B |
What is the price of RNR shares?
As of February 08, 2026, the stock is trading at USD 300.56 with a total of 323,418 shares traded.
Over the past week, the price has changed by +6.70%, over one month by +10.50%, over three months by +13.04% and over the past year by +25.56%.
Over the past week, the price has changed by +6.70%, over one month by +10.50%, over three months by +13.04% and over the past year by +25.56%.
Is RNR a buy, sell or hold?
Renaissancere Holdings has received a consensus analysts rating of 3.42.
Therefor, it is recommend to hold RNR.
- StrongBuy: 2
- Buy: 4
- Hold: 4
- Sell: 1
- StrongSell: 1
What are the forecasts/targets for the RNR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 305.9 | 1.8% |
| Analysts Target Price | 305.9 | 1.8% |
| ValueRay Target Price | 341.4 | 13.6% |
RNR Fundamental Data Overview February 07, 2026
P/E Trailing = 5.3652
P/E Forward = 9.3633
P/S = 1.0775
P/B = 1.236
P/EG = -3.13
Revenue TTM = 12.79b USD
EBIT TTM = 2.84b USD
EBITDA TTM = 3.63b USD
Long Term Debt = 2.23b USD (from longTermDebt, two quarters ago)
Short Term Debt = unknown (none)
Debt = 2.33b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 598.0m USD (from netDebt column, last quarter)
Enterprise Value = 14.46b USD (13.86b + Debt 2.33b - CCE 1.73b)
Interest Coverage Ratio = 5.30 (Ebit TTM 2.84b / Interest Expense TTM 536.2m)
EV/FCF = 3.62x (Enterprise Value 14.46b / FCF TTM 3.99b)
FCF Yield = 27.59% (FCF TTM 3.99b / Enterprise Value 14.46b)
FCF Margin = 31.18% (FCF TTM 3.99b / Revenue TTM 12.79b)
Net Margin = 20.96% (Net Income TTM 2.68b / Revenue TTM 12.79b)
Gross Margin = 35.28% ((Revenue TTM 12.79b - Cost of Revenue TTM 8.28b) / Revenue TTM)
Gross Margin QoQ = 43.92% (prev 51.70%)
Tobins Q-Ratio = 0.30 (Enterprise Value 14.46b / Total Assets 48.91b)
Interest Expense / Debt = 19.18% (Interest Expense 446.7m / Debt 2.33b)
Taxrate = 13.38% (116.1m / 867.7m)
NOPAT = 2.46b (EBIT 2.84b * (1 - 13.38%))
Current Ratio = 0.67 (Total Current Assets 14.39b / Total Current Liabilities 21.48b)
Debt / Equity = 0.20 (Debt 2.33b / totalStockholderEquity, last quarter 11.61b)
Debt / EBITDA = 0.16 (Net Debt 598.0m / EBITDA 3.63b)
Debt / FCF = 0.15 (Net Debt 598.0m / FCF TTM 3.99b)
Total Stockholder Equity = 11.06b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.39% (Net Income 2.68b / Total Assets 48.91b)
RoE = 24.24% (Net Income TTM 2.68b / Total Stockholder Equity 11.06b)
RoCE = 21.36% (EBIT 2.84b / Capital Employed (Equity 11.06b + L.T.Debt 2.23b))
RoIC = 19.60% (NOPAT 2.46b / Invested Capital 12.55b)
WACC = 8.50% (E(13.86b)/V(16.19b) * Re(7.14%) + D(2.33b)/V(16.19b) * Rd(19.18%) * (1-Tc(0.13)))
Discount Rate = 7.14% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -6.26%
[DCF Debug] Terminal Value 79.64% ; FCFF base≈3.95b ; Y1≈4.88b ; Y5≈8.30b
Fair Price DCF = 2883 (EV 127.34b - Net Debt 598.0m = Equity 126.74b / Shares 44.0m; r=8.50% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 27.86 | EPS CAGR: 42.88% | SUE: 1.54 | # QB: 3
Revenue Correlation: 83.00 | Revenue CAGR: 38.20% | SUE: 3.49 | # QB: 2
EPS next Quarter (2026-03-31): EPS=11.17 | Chg30d=+0.854 | Revisions Net=+4 | Analysts=12
EPS current Year (2026-12-31): EPS=37.25 | Chg30d=+1.411 | Revisions Net=+14 | Growth EPS=-4.7% | Growth Revenue=-8.3%
EPS next Year (2027-12-31): EPS=43.35 | Chg30d=+5.316 | Revisions Net=+1 | Growth EPS=+16.0% | Growth Revenue=+5.1%
P/E Forward = 9.3633
P/S = 1.0775
P/B = 1.236
P/EG = -3.13
Revenue TTM = 12.79b USD
EBIT TTM = 2.84b USD
EBITDA TTM = 3.63b USD
Long Term Debt = 2.23b USD (from longTermDebt, two quarters ago)
Short Term Debt = unknown (none)
Debt = 2.33b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 598.0m USD (from netDebt column, last quarter)
Enterprise Value = 14.46b USD (13.86b + Debt 2.33b - CCE 1.73b)
Interest Coverage Ratio = 5.30 (Ebit TTM 2.84b / Interest Expense TTM 536.2m)
EV/FCF = 3.62x (Enterprise Value 14.46b / FCF TTM 3.99b)
FCF Yield = 27.59% (FCF TTM 3.99b / Enterprise Value 14.46b)
FCF Margin = 31.18% (FCF TTM 3.99b / Revenue TTM 12.79b)
Net Margin = 20.96% (Net Income TTM 2.68b / Revenue TTM 12.79b)
Gross Margin = 35.28% ((Revenue TTM 12.79b - Cost of Revenue TTM 8.28b) / Revenue TTM)
Gross Margin QoQ = 43.92% (prev 51.70%)
Tobins Q-Ratio = 0.30 (Enterprise Value 14.46b / Total Assets 48.91b)
Interest Expense / Debt = 19.18% (Interest Expense 446.7m / Debt 2.33b)
Taxrate = 13.38% (116.1m / 867.7m)
NOPAT = 2.46b (EBIT 2.84b * (1 - 13.38%))
Current Ratio = 0.67 (Total Current Assets 14.39b / Total Current Liabilities 21.48b)
Debt / Equity = 0.20 (Debt 2.33b / totalStockholderEquity, last quarter 11.61b)
Debt / EBITDA = 0.16 (Net Debt 598.0m / EBITDA 3.63b)
Debt / FCF = 0.15 (Net Debt 598.0m / FCF TTM 3.99b)
Total Stockholder Equity = 11.06b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.39% (Net Income 2.68b / Total Assets 48.91b)
RoE = 24.24% (Net Income TTM 2.68b / Total Stockholder Equity 11.06b)
RoCE = 21.36% (EBIT 2.84b / Capital Employed (Equity 11.06b + L.T.Debt 2.23b))
RoIC = 19.60% (NOPAT 2.46b / Invested Capital 12.55b)
WACC = 8.50% (E(13.86b)/V(16.19b) * Re(7.14%) + D(2.33b)/V(16.19b) * Rd(19.18%) * (1-Tc(0.13)))
Discount Rate = 7.14% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -6.26%
[DCF Debug] Terminal Value 79.64% ; FCFF base≈3.95b ; Y1≈4.88b ; Y5≈8.30b
Fair Price DCF = 2883 (EV 127.34b - Net Debt 598.0m = Equity 126.74b / Shares 44.0m; r=8.50% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 27.86 | EPS CAGR: 42.88% | SUE: 1.54 | # QB: 3
Revenue Correlation: 83.00 | Revenue CAGR: 38.20% | SUE: 3.49 | # QB: 2
EPS next Quarter (2026-03-31): EPS=11.17 | Chg30d=+0.854 | Revisions Net=+4 | Analysts=12
EPS current Year (2026-12-31): EPS=37.25 | Chg30d=+1.411 | Revisions Net=+14 | Growth EPS=-4.7% | Growth Revenue=-8.3%
EPS next Year (2027-12-31): EPS=43.35 | Chg30d=+5.316 | Revisions Net=+1 | Growth EPS=+16.0% | Growth Revenue=+5.1%